The increase in price target by Wells Fargo suggests a positive outlook on Merck & Co's stock, potentially leading to increased investor confidence and a short-term upward movement in the stock price. The Equal-Weight rating indicates that the stock is expected to perform in line with the market or sector, but the raised target suggests specific optimism about Merck's prospects.